Liposomal doxorubicin effective for advanced breast cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1460, 2004-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liposomal doxorubicin vs epirubicin in breast cancer

Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Liposomal doxorubicin in combination with vinorelbine shows promise as a treatment for patients with pretreated advanced breast cancer

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Doxorubicin liposomal + docetaxel: efficacy in metastatic breast cancer?

Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Doxorubicin more `toxic' than paclitaxel in advanced breast cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 281, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Pegylated liposomal doxorubicin is active and well tolerated in elderly women with metastatic breast cancer

Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite